Showing results (1901-1910 of 2,187) with videos related to

Sort By:
Pageof 219
The British Journal of Psychiatry : the Journal of Mental Science|January 27, 2022
Changes in brain function during negative emotion processing in the long-term course of depressionVerena Enneking, Melissa Klug, Tiana Borgers, et al.
Arxiv|November 24, 2025
Low-N Protein Activity Optimization with FolDEJacob B Roberts, Catherine R Ji, Isaac Donnell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 22, 2024
Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R-LIVER)Ida Schregel, Maria Papp, Nora Sipeki, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2022
Coordination and expertise foster legal textualismIvar R Hannikainen, Kevin P Tobia, Guilherme da F C F de Almeida, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|August 10, 2011
Itinerant spin excitations near the hidden order transition in URu(2)Si(2)J A Janik, H D Zhou, Y-J Jo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancyDeirdre O'Mahony, John C Morris, Cate Quinn, et al.
Addiction (Abingdon, England)|December 5, 2022
Classifying alcohol control policies enacted between 2000 and 2020 in Poland and the Baltic countries to model potential impactJürgen Rehm, Shannon Lange, Inese Gobiņa, et al.
Clinical Immunology (Orlando, Fla.)|October 1, 2014
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphomaJonathan L Berkowitz, John E Janik, Donn M Stewart, et al.
The Journal of Infectious Diseases|April 28, 2010
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trialDavid M Asmuth, Robert L Murphy, Susan L Rosenkranz, et al.
Pageof 219